Use of relative survival to evaluate non-ST-elevation myocardial infarction quality of care and clinical outcomes

European Heart Journal - Quality of Care and Clinical Outcomes

Volumn 1, Issue 2, 2015, Pages 85-91

  Hall, Marlous ^a   Alabas, Oras A ^a   Dondo, Tatendashe B ^a   Jernberg, Tomas ^b,c   Gale, Chris P ^a,c  

^a UNIVERSITY OF LEEDS   (United Kingdom)

^b KAROLINSKA UNIVERSITY HOSPITAL   (Sweden)

^c YORK TEACHING HOSPITAL NHS FOUNDATION TRUST   (United Kingdom)

Author keywords

Excess mortality; NSTEMI; Observational studies; Relative survival

Indexed keywords

ADULT; AGE; AGED; ALL CAUSE MORTALITY; ARTICLE; CARDIAC PATIENT; CLINICAL OUTCOME; COHORT ANALYSIS; CONTROLLED STUDY; FEMALE; HEALTH CARE QUALITY; HUMAN; MAJOR CLINICAL STUDY; MALE; NON ST SEGMENT ELEVATION MYOCARDIAL INFARCTION; OBSERVATIONAL STUDY; PRIORITY JOURNAL; RELATIVE SURVIVAL; SURVIVAL;

EID: 84983441207     PISSN: 20585225     EISSN: 20581742     Source Type: Journal    
DOI: 10.1093/ehjqcco/qcv011     Document Type: Article

References (41)

1. Gale C, Cattle B, Baxter P, Greenwood D, Simms A, Deanfield J, Fox KAA, Hall AS, West RM. Age-dependent inequalities in improvements in mortality occur early after acute myocardial infarction in 478,242 patients in the Myocardial Ischaemia National Audit Project (MINAP) registry. Int J Cardiol 2013;168:881-887.
2. Gale C, Cattle B, Woolston A, Baxter P, West T, Simms A, Blaxill J, Greenwood DC, Fox KAA,West RM. Resolving inequalities in care? Reduced mortality in the elderly after acute coronary syndromes. The Myocardial Ischaemia National Audit Project 2003-2010. Eur Heart J 2011:ehr381.
3. Smolina K, Wright F, Rayner M, Goldacre M. Determinants of the decline in mortality from acute myocardial infarction in England between 2002 and 2010: linked national database study. BMJ 2012;344:d8059.
4. Pearson-Stuttard J, Bajekal M, Scholes S, O'Flaherty M, Hawkins N, Raine R, Capewell S. Recent UK trends in the unequal burden of coronary heart disease. Heart 2012;98:1573-1582.
5. Hemingway H, Croft P, Perel P, Hayden J, Abrams K, Timmis A, Briggs A, Udumyan R, Steyerberg EW, Schroter S, Altman DG, Riley RD. Prognosis research strategy (PROGRESS) 1: a framework for researching clinical outcomes. BMJ 2013; 346:e5595-e5606.
6. Mathers C, Loncar D. Projections of global mortality and burden of disease from 2002 to 2030. PLoS Med 2006;3:e442.
7. Spoon D, Psaltis P, Singh M, Holmes D, Gersh B, Rihal C, Lennon RJ, Moussa ID, Simari RD, Gulati R. Trends in cause of death after percutaneous coronary intervention. Circulation 2014; doi: 10.1161/CIRCULATIONAHA.113.006518.
8. Nelson C, Lambert P, Squire I, Jones D. Relative survival: what can cardiovascular disease learn from cancer? Eur Heart J 2008;29:941-947.
9. Dickman P, Sloggett A, Hills M, Hakulinen T. Regression models for relative survival. Stat Med 2004;23:51-64.
10. Dickman P, Adami HO. Interpreting trends in cancer patient survival. J Intern Med 2006;260:103-117.
11. Begg C, Schrag D. Attribution of deaths following cancer treatment. JNCI 2002;94: 1044-1045.
12. Engel L, Strauchen J, Chiazze L, Heid M. Accuracy of death certification in an autopsied population with specific attention to malignant neoplasms and vascular diseases. Am J Epidemiol 1980;111:99-112.
13. Percy C, Stanek E, Gloeckler L. Accuracy of cancer death certificates and its effect on cancer mortality statistics. Am J Public Health 1981;71:242-250.
14. Welch H, Black W. Are deaths within 1 month of cancer-directed surgery attributed to cancer? JNCI 2002;94:1066-1070.
15. Lauer M, Blackstone E, Young J, Topol E. Cause of death in clinical research: time for a reassessment? JACC 1999;34:618-620.
16. Lloyd-Jones D, Martin D, Larson M, Levy D. Accuracy of death certificates for coding coronary heart disease as the cause of death. Ann Intern Med 1998;129: 1020-1026.
17. Mant J, Wilson S, Parry J, Bridge P, Wilson R, Murdoch W, Quirke T, Davies M, Gammage M, Harrison R. Clinicians didn't reliably distinguish between different causes of cardiac death using case histories. JCE 2006;59:862-867.
18. Ederer F, Axtell L, Cutler S. The relative survival rate: a statistical methodology. JNCI Monogr 1961;6:101-121.
19. Remontet L, Bossard N, Belot A, Esteve J. An overall strategy based on regression models to estimate relative survival and model the effects of prognostic factors in cancer survival studies. Stat Med 2007;26:2214-2228.
20. Nelson C, Lambert P, Squire I, Jones D. Flexible parametric models for relative survival, with application in coronary heart disease. Stat Med 2007;26:5486-5498.
21. Brønnum-Hansen H, Jørgensen T, Davidsen M, Madsen M, Osler M, Gerdes L, Schroll M. Survival and cause of death after myocardial infarction: the Danish MONICA study. JCE 2001;54:1244-1250.
22. Dickman P, Coviello E. Estimating and modelling relative survival. Stata J 2015;15: 186-215.
23. GAD. Interim life tables of mortality rates for England andWales. http://www.gad. gov.uk/. In: Government Actuary's Department, editor. 2014.
24. Cancer Research UK Cancer Survival Group. Life tables for cancer survival analysis. Department of Non-Communicable Disease Epidemiology, London School of Hygiene & Tropical Medicine, UK. wwwlshtmacuk/ncde/cancersurvival/toolshtm (April 2015).
25. See more at: http://wwwlshtmacuk/eph/ncde/cancersurvival/tools/acknowledgement/indexhtml#sthashoTw36tWbdpuf. 2006.
26. Cho H, Howlader N, Mariotto A, Cronin K. Estimating relative survival for cancer patients from the SEER Program using expected rates based on Ederer I versus Ederer II method. Surveillance Research Program, NCI, Technical Report# 2011. 2011;1.
27. Hakulinen T. Cancer survival corrected for heterogeneity in patient withdrawal. Biometrics 1982;38:933-942.
28. Ederer F, Heise H. Instructions to IBM 650 programmers in processing survival computations. Methodol Note 1959;10.
29. Rutherford M, Dickman P, Lambert P. Comparison of methods for calculating relative survival in population-based studies. Cancer Epidemiol 2012;36:16-21.
30. Perme M, Stare J, Estéve J. On estimation in relative survival. Biometrics 2012;68: 113-120.
31. Royston P, Lambert P. Flexible Parametric Survival Analysis Using Stata: Beyond the Cox Model. TX, USA: Stata Press Books; 2011.
32. Eloranta S, Adolfsson J, Lambert P, Stattin P, Akre O, Andersson T, Dickman PW. How can we make cancer survival statistics more useful for patients and clinicians: an illustration using localized prostate cancer in Sweden. Cancer Causes Control 2013;24:505-515.
33. Lambert P, Dickman P, Nelson C, Royston P. Estimating the crude probability of death due to cancer and other causes using relative survival models. Stat Med 2010;29:885-895.
34. Royston P, Parmar M. Flexible parametric proportional-hazards and proportionalodds models for censored survival data, with application to prognostic modelling and estimation of treatment effects. Stat Med 2002;21:2175-2197.
35. Cox DR. Models and life-tables regression. JR Stat Soc Ser B 1972;34:187-220.
36. Hjort N. On inference in parametric survival data models. Int Stat Rev/Rev Int Stat 1992;60:355-387.
37. Jernberg T, Hasvold P, Henriksson M, Hjelm H, Thuresson M, Janzon M. Cardiovascular risk in post-myocardial infarction patients: nationwide real world data demonstrate the importance of a long-term perspective. Eur Heart J 2015; doi:10.1093/eurheartj/ehu505.
38. Herrett E, Smeeth L,Walker L,Weston C. The myocardial ischaemia national audit project (MINAP). Heart 2010;96:1264-1267.
39. Gale CP,Weston C, Denaxas S, Cunningham D, de Belder MA, Gray HH, Boyle R, Deanfield JE. Engaging with the clinical data transparency initiative: a view from the National Institute for Cardiovascular Outcomes Research (NICOR). Heart 2012; 98:1040-1043.
40. Rutherford M, Crowther M, Lambert P. The use of restricted cubic splines to approximate complex hazard functions in the analysis of time-to-event data: a simulation study. J Stat Comput Simul 2015;85:777-793.
41. van Laar M, Feltbower R, Gale C, Bowen D, Oliver S, Glaser A. Cardiovascular sequelae in long-term survivors of young peoples' cancer: a linked cohort study. BJC 2014;110:1338-1341.